Skip to Main Content

Paper Details

A pharmacokinetic-pharmacodynamic model predicting tumour growth inhibition after intermittent administration with the mTOR kinase inhibitor AZD8055.
Br J Pharmacol
7
2017

Datasets

Release 1.2